Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Dec;25(12):3244-3257.
doi: 10.1007/s11605-021-05115-w. Epub 2021 Sep 10.

Radioguided Surgery for Gastroenteropancreatic Neuroendocrine Tumours: a Systematic Literature Review

Affiliations

Radioguided Surgery for Gastroenteropancreatic Neuroendocrine Tumours: a Systematic Literature Review

Katrina Clair Cockburn et al. J Gastrointest Surg. 2021 Dec.

Abstract

Background: Radioguided surgery (RGS) for gastroenteropancreatic neuroendocrine tumours (GEP-NETs) has been suggested as a way to improve intraoperative lesion detection. This systematic literature review of reports of the use of RGS for GEP-NETs was performed to determine if there is a benefit.

Methods: A literature search was conducted using Google Scholar and PubMed, and snowballing from any relevant literature. Full-text studies were included if they were published in the English language and reported outcomes of RGS on human subjects with GEP-NETs. Qualitative data synthesis was performed.

Results: Twenty-six papers including a total of 209 patients were included. The tracers used were predominantly indium-111 pentetreotide, gallium-68 DOTA-peptides, and technetium-99m EDDA/HYNIC-peptides. Heterogeneous protocols make comparisons difficult, but most papers reported a benefit from the use of RGS in tumours in the gastrointestinal tract; utility in localisation of pancreatic tumours was less clear. Time between tracer administration and operation varied: from 16 h to 8 days with indium-111, 0-24 h with technetium-99m, and 19-193 min with gallium-68. Eight teams reported the thresholding technique used for discrimination-four used a ratio, four statistical methods, and one looked at the sensitivity and specificity of different cut-offs. Six teams performed follow-up of 24 patients (three pancreas, eight gastrinoma, 13 gastrointestinal tract) for between 3 months and 3 years. Two patients relapsed (one pancreas, one gastrinoma) between 6 and 12 months post-surgery.

Conclusions: RGS appears to aid in localisation of gastrointestinal NETs, but the benefit is more equivocal in pancreatic NETs. Further work into outcomes is warranted.

Keywords: Diagnostic techniques; Neuroendocrine tumours/surgery; Radioisotope; Radiopharmaceutical.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
PRISMA flow diagram for literature search

References

    1. G. Delle Fave et al., “Gastroenteropancreatic neuroendocrine tumours,” Lancet Oncol., vol. 9, no. 1, pp. 61–72, 2008 - PubMed
    1. S. Adams and R. P. Baum, “Intraoperative use of gamma-detecting probes to localize neuroendocrine tumors,” Q.J.Nucl.Med., vol. 44, no. 1125–0135 (Print), pp. 59–67, 2000 - PubMed
    1. Lawrence B, Gustafsson BI, Chan A, Svejda B, Kidd M, Modlin IM. The Epidemiology of Gastroenteropancreatic Neuroendocrine Tumors. Endocrinol. Metab. Clin. North Am. 2011;40(1):1–18. doi: 10.1016/j.ecl.2010.12.005. - DOI - PubMed
    1. S. Massironi, V. Sciola, M. Peracchi, C. Ciafardini, M. P. Spampatti, and D. Conte, “Neuroendocrine tumors of the gastro-entero-pancreatic system,” World Journal of Gastroenterology, vol. 14, no. 35. Baishideng Publishing Group Inc, pp. 5377–5384, 2008 - PMC - PubMed
    1. Cuccurullo V, Di Stasio GD, Mansi L, Cuccurullo V, Danilo G, Stasio D. Radioguided surgery with radiolabeled somatostatin analogs: not only in GEP-NETs. Nucl. Med. Rev. 2017;20(1):49–56. doi: 10.5603/NMR.2017.0003. - DOI - PubMed

Publication types

MeSH terms